Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

IDEXX Laboratories Inc (NASDAQ:IDXX)

153.96
Delayed Data
As of Mar 27
 +0.22 / +0.14%
Today’s Change
75.03
Today|||52-Week Range
154.57
+31.29%
Year-to-Date
Who Will Win the March Madness of Trump Stocks?
Mar 23 / Zacks.com - Paid Partner Content
3 Medical Device Stocks to Brave Policy Uncertainty
Mar 16 / Zacks.com - Paid Partner Content
Snap's Cinderella Story Continues to Unfold as Nike Squeaks By AT&T: An Update From t...
Mar 23 / TheStreet.com - Paid Partner Content
IDEXX (IDXX) Poised on Strong Fundamentals, Innovations
Mar 15 / Zacks.com - Paid Partner Content
MedTech Long-Term Prospects Impress: Which Stocks to Buy?
Mar 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close153.74
Today’s open152.98
Day’s range151.80 - 154.49
Volume460,058
Average volume (3 months)914,873
Market cap$13.5B
Dividend yield--
Data as of 03/27/2017

Growth & Valuation

Earnings growth (last year)+19.02%
Earnings growth (this year)+20.46%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+10.83%
P/E ratio63.1
Price/Sales6.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALRAlere Inc-0.10-0.26%
NEOGNeogen Corp+1.06+1.66%
AAAPAdvanced Accelerator...+0.22+0.56%
MYGNMyriad Genetics Inc-0.13-0.67%
Data as of 03/27/2017

Financials

Next reporting dateApril 28, 2017
EPS forecast (this quarter)$0.62
Annual revenue (last year)$1.8B
Annual profit (last year)$222.0M
Net profit margin12.51%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Jonathan W. Ayers
Chief Financial Officer, Treasurer &
Executive VP
Brian P. McKeon
Corporate headquarters
Westbrook, Maine

Forecasts


Search for Jobs